URYPAB traded at 0.0257335 this Monday February 2nd, increasing 0.0003595 or 1.42 percent since the previous trading session. Looking back, over the last four weeks, URYPAB gained 0.50 percent. Over the last 12 months, its price rose by 11.50 percent. Looking ahead, we forecast URYPAB to be priced at 0.0258156 by the end of this quarter and at 0.0260312 in one year, according to Trading Economics global macro models projections and analysts expectations.